Pde10 cell-based assay and sequences

Details Pde10 cell-based assay and sequences Pde10 cell-based assay and sequences

C - Chemistry, Metallurgy

12

N

C12N 15/12 (2006.01) C12N 9/16 (2006.01) C12Q 1/44 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) G01N 33/573 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2391117

The invention features a method of creeping for an agent that inhibits intracellular phosphodiesterase 10A activity, comprising administering an agent to striatal medium spiny neurons and submaximally activating adenylate cyclase; administering an agent to striatal medium spiny neurons and submaximally activating guanylate cyclase, measuring cAMP generation and cGMP generation in the cells, and calculating the cAMP EC200 and the cGMP EC200, wherein the agent is identified as a PDE10A inhibitor if the ratio of cAMP EC200/ cGMP EC200 is comparable to the ratio produced by administration of papaverine under the same assay conditions. Also featured are rat PDE10A polynucleotide and polypeptide sequences.

Affiliated with

Also associated with

Rating

Pde10 cell-based assay and sequences does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pde10 cell-based assay and sequences, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pde10 cell-based assay and sequences will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1515814